Endocrine Abstracts

Background and aims: HbA1c as a gold-standard measure for glycaemic control has been criticized for several years: lacking the ability to capture hypoglycaemia, time spent in different glucose ranges or to reflect glycaemic variability (GV) are frequently reported shortcomings. Continuous glucose monitoring (CGM) can overcome this, and several new CGM-derived parameters have been proposed to provide additional insights, with the concept of time in range (TIR) and other paramet...